English
Last update : February 03, 2011
Laboratoires Expanscience
Since their creation in 1950, Laboratoires Expanscience have launched a number of innovative products onto the health and well-being markets and have developed expertise in the fields of Dermocosmetics, Rheumatology, Dentistry, Dermatology and Active Cosmetic Ingredients. Complementary activities progressing in perfect synergy.
Furthermore, Laboratoires Expanscience have become unavoidable through:
- their healthcare products for babies and pregnant women: Mustela ® Baby and Mustela ® 9 Months (stretch mark treatment), are European leaders in pharmacies,
- Piascledine 300 ®, a leader in France for the symptomatic treatment of osteoarthritis.
Pharmacy represents a strategic hinge pin for the development of Laboratoires Expanscience. The company has thus opted for selective distribution with a pharmacist present. Indeed, most of the company's products require this expert advice, along with medical recommendations or prescription.
Thanks to the commitment of its 964 associates and to a strong international presence, via its 8 subsidiaries and over 59 contract distribution countries, Laboratoires Expanscience generated a turnover of 233 million Euros in 2009.
Finally, Laboratoires Expanscience benefit from solid Research and Development assets, thanks to their R&D Centre, whose work has led to the filing of more than 50 patents over the past decade.
Since 2004, the company is also strongly involved in favour of sustainable development. This policy permeates all of the company's activities and is supplemented by a specific action plan.
